Advocates are urging U.S. House members to support a FY2026 appropriations bill that keeps NIH funding at the Senate-approved $48.7 billion and preserves Senate language on indirect-cost caps and limits to multi-year grants. The call to action frames the provisions as critical to sustaining biomedical research funding and institutional research capacity. The appeal, circulated alongside policy explainer links, seeks to avert a policy shift that could reduce multi-year grant support and impose indirect cost caps — moves that researchers warn would destabilize labs and slow translational programs. Industry groups and academic stakeholders are positioned to lobby lawmakers as appropriations negotiations proceed.